Expanding the CRO business platform by making イナリサーチ a wholly owned subsidiary
A theme centered on expanding the order base and business scale of the pharmaceutical development support business by making イナリサーチ a wholly owned subsidiary and bringing in nonclinical testing and CRO capabilities.
Companies1How many companies write about this.
Threads1One company can carry more than one thread here.